{"hands_on_practices": [{"introduction": "A competitive inhibitor works by binding to the enzyme's active site, increasing the amount of substrate needed to reach half of the maximum velocity. This effect is quantified as an increase in the apparent Michaelis constant, $K_{M,app}$. This first exercise provides a fundamental calculation, demonstrating how to determine the new apparent $K_M$ in the presence of a known concentration of a competitive inhibitor [@problem_id:2110262].", "problem": "Researchers are investigating a novel therapeutic agent designed to inhibit a specific enzyme implicated in a metabolic disease. This inhibitor is known to bind reversibly to the enzyme's active site, thereby preventing the natural substrate from binding. The Michaelis constant ($K_M$) of the enzyme for its substrate has been determined to be $2.0$ mM. The inhibition constant ($K_i$), which represents the dissociation constant for the enzyme-inhibitor complex, is measured to be $2.5$ mM. In an experiment, the enzyme's activity is assayed in the presence of the inhibitor at a concentration of $5.0$ mM. Under these conditions, the enzyme exhibits modified kinetics, characterized by an apparent Michaelis constant ($K_{M,app}$). Calculate the value of this apparent Michaelis constant. Express your answer in units of mM, rounded to two significant figures.", "solution": "The inhibitor binds reversibly at the active site and competes with the substrate, which corresponds to competitive inhibition. For competitive inhibition, the apparent Michaelis constant increases by the factor $\\alpha$, with\n$$\n\\alpha = 1 + \\frac{[I]}{K_{i}},\n$$\nand the apparent Michaelis constant is\n$$\nK_{M,\\text{app}} = \\alpha K_{M} = K_{M}\\left(1 + \\frac{[I]}{K_{i}}\\right).\n$$\nUsing the given values $K_{M} = 2.0$ mM, $K_{i} = 2.5$ mM, and $[I] = 5.0$ mM, compute\n$$\n\\alpha = 1 + \\frac{5.0}{2.5} = 1 + 2 = 3,\n$$\nso\n$$\nK_{M,\\text{app}} = 3 \\times 2.0\\ \\text{mM} = 6.0\\ \\text{mM}.\n$$\nRounded to two significant figures, the value is $6.0$ in units of mM.", "answer": "$$\\boxed{6.0}$$", "id": "2110262"}, {"introduction": "In a laboratory setting, the type of inhibition is not always known beforehand; it must be determined experimentally. By measuring reaction rates at various substrate concentrations, both with and without an inhibitor, we can deduce the mechanism of action. This practice challenges you to act as a biochemist, analyzing a set of kinetic data to determine an inhibitor's mechanism by observing its effect on $V_{max}$ and $K_M$ [@problem_id:1432075].", "problem": "A team of biochemists is developing a new drug candidate, \"Compound Y-31,\" intended to treat a metabolic disorder caused by the over-activity of a specific enzyme, Fumarate-Malate Dehydrogenase (FMDH). To characterize the interaction of Compound Y-31 with FMDH, they conducted a series of kinetic experiments. The initial reaction velocity ($v_0$) was measured at various concentrations of the substrate, fumarate ($[S]$), both in the absence and in the presence of a fixed concentration of Compound Y-31. The collected data are presented in the table below.\n\n| Substrate Concentration, $[S]$ ($\\mu$M) | Initial Velocity without Inhibitor, $v_0$ ($\\mu$M/min) | Initial Velocity with Inhibitor, $v_0$ ($\\mu$M/min) |\n|:---:|:---:|:---:|\n| 2.0 | 16.7 | 7.4  |\n| 5.0 | 33.3 | 16.7 |\n| 10.0| 50.0 | 28.6 |\n| 20.0| 66.7 | 44.4 |\n| 50.0| 83.3 | 66.7 |\n\nBased on these experimental data, determine the mechanism of inhibition that Compound Y-31 exerts on the FMDH enzyme.\n\nA. Competitive inhibition\n\nB. Non-competitive inhibition\n\nC. Uncompetitive inhibition\n\nD. Substrate inhibition\n\nE. No inhibition", "solution": "We assume Michaelis–Menten kinetics. The initial velocity as a function of substrate concentration is\n$$\nv=\\frac{V_{\\max}[S]}{K_{m}+[S]}.\n$$\nFirst determine $V_{\\max}$ and $K_{m}$ from the data without inhibitor. Using two data points:\n- At $[S]=10$, $v=50$:\n$$\n50=\\frac{V_{\\max}\\cdot 10}{K_{m}+10}\\;\\Rightarrow\\;V_{\\max}=5\\left(K_{m}+10\\right).\n$$\n- At $[S]=20$, $v=66.7$. Interpreting the recurring decimal $66.7$ as $66.\\overline{6}=\\frac{200}{3}$,\n$$\n\\frac{200}{3}=\\frac{V_{\\max}\\cdot 20}{K_{m}+20}\\;\\Rightarrow\\;V_{\\max}=\\frac{200}{3}\\cdot\\frac{K_{m}+20}{20}=\\frac{10}{3}\\left(K_{m}+20\\right).\n$$\nEquating the two expressions for $V_{\\max}$,\n$$\n5\\left(K_{m}+10\\right)=\\frac{10}{3}\\left(K_{m}+20\\right)\\;\\Rightarrow\\;15K_{m}+150=10K_{m}+200\\;\\Rightarrow\\;5K_{m}=50\\;\\Rightarrow\\;K_{m}=10,\n$$\nand then\n$$\nV_{\\max}=5\\left(10+10\\right)=100.\n$$\n\nNow analyze the inhibited data. For competitive inhibition at fixed inhibitor concentration $[I]$, the Michaelis–Menten form is\n$$\nv=\\frac{V_{\\max}[S]}{\\alpha K_{m}+[S]},\\quad \\alpha=1+\\frac{[I]}{K_{i}},\n$$\nso $V_{\\max}$ is unchanged and the apparent Michaelis constant is $K_{m,\\text{app}}=\\alpha K_{m}$. Using $V_{\\max}=100$ and one inhibited datapoint to solve for $K_{m,\\text{app}}$:\n- At $[S]=50$, $v=66.7=66.\\overline{6}=\\frac{200}{3}$,\n$$\n\\frac{200}{3}=\\frac{100\\cdot 50}{K_{m,\\text{app}}+50}\\;\\Rightarrow\\;K_{m,\\text{app}}+50=\\frac{5000}{200/3}=75\\;\\Rightarrow\\;K_{m,\\text{app}}=25.\n$$\nCheck consistency at another substrate concentration:\n- At $[S]=20$, prediction with $V_{\\max}=100$, $K_{m,\\text{app}}=25$ is\n$$\nv=\\frac{100\\cdot 20}{25+20}=\\frac{2000}{45}=\\frac{400}{9}=44.\\overline{4},\n$$\nwhich matches the reported $44.4$. Similarly, at $[S]=10$ the prediction is $v=\\frac{100\\cdot 10}{25+10}=\\frac{1000}{35}=\\frac{200}{7}\\approx 28.6$, at $[S]=5$ it is $v=\\frac{500}{30}=\\frac{50}{3}=16.\\overline{6}$, and at $[S]=2$ it is $v=\\frac{200}{27}=7.\\overline{407}$, all matching the inhibited data.\n\nThus, the inhibited data are exactly described by $V_{\\max}$ unchanged at $100$ and $K_{m}$ increased from $10$ to $25$, i.e., $K_{m,\\text{app}}=\\alpha K_{m}$ with $\\alpha=\\frac{25}{10}=2.5$, which is the hallmark of competitive inhibition. Alternative mechanisms are inconsistent: non-competitive inhibition would decrease $V_{\\max}$ with $K_{m}$ unchanged, and uncompetitive inhibition would decrease both $V_{\\max}$ and $K_{m}$ in the same proportion; neither matches the observed parameter changes.", "answer": "$$\\boxed{A}$$", "id": "1432075"}, {"introduction": "In the field of drug development, comparing the effectiveness of different inhibitor candidates is a critical task. The inhibition constant, $K_i$, serves as a direct measure of an inhibitor's potency—a lower $K_i$ signifies tighter binding and thus a more potent drug. This problem explores the practical implications of $K_i$ by asking you to compare the concentrations of two different drugs required to achieve the same therapeutic effect [@problem_id:1432092].", "problem": "In a drug discovery program, a research team is investigating two potential therapeutic compounds, named Compound P and Compound Q, designed to inhibit a critical enzyme. This enzyme follows Michaelis-Menten kinetics with a Michaelis constant, $K_M$, of $40.0 \\text{ \\mu M}$ and a maximum velocity, $V_{max}$, of $150.0 \\text{ \\mu M/s}$. Both compounds are found to be competitive inhibitors. Compound P has an inhibition constant, $K_{i,P}$, of $25.0 \\text{ nM}$, while Compound Q has an inhibition constant, $K_{i,Q}$, of $125.0 \\text{ nM}$.\n\nThe therapeutic objective is to administer a sufficient concentration of one of these inhibitors to reduce the enzyme's reaction velocity to precisely 30.0% of its uninhibited velocity. This must be achieved under physiological conditions where the substrate concentration, $[S]$, is stable at $80.0 \\text{ \\mu M}$.\n\nLet $[I_P]$ be the required concentration of Compound P to achieve this therapeutic objective, and let $[I_Q]$ be the required concentration of Compound Q to achieve the same objective. Calculate the dimensionless ratio $\\frac{[I_Q]}{[I_P]}$. Round your final answer to three significant figures.", "solution": "For an enzyme following Michaelis-Menten kinetics with a competitive inhibitor, the rate in the presence of inhibitor at concentration $[I]$ is\n$$\nv=\\frac{V_{\\max}[S]}{\\alpha K_{M}+[S]},\\quad \\text{with}\\quad \\alpha=1+\\frac{[I]}{K_{i}}.\n$$\nThe uninhibited rate is\n$$\nv_{0}=\\frac{V_{\\max}[S]}{K_{M}+[S]}.\n$$\nAt fixed substrate concentration, the fractional activity $r$ under inhibition is\n$$\nr=\\frac{v}{v_{0}}=\\frac{K_{M}+[S]}{\\alpha K_{M}+[S]}.\n$$\nSolving for $\\alpha$ in terms of $r$, $K_{M}$, and $[S]$:\n$$\nr\\left(\\alpha K_{M}+[S]\\right)=K_{M}+[S]\\;\\Rightarrow\\; r\\alpha K_{M}=K_{M}+[S]-r[S]\n$$\n$$\n\\Rightarrow\\;\\alpha=\\frac{K_{M}+(1-r)[S]}{rK_{M}}.\n$$\nRelating $\\alpha$ to inhibitor concentration gives\n$$\n[I]=(\\alpha-1)K_{i}.\n$$\nTherefore, for two competitive inhibitors P and Q that achieve the same target $r$, their required concentrations satisfy\n$$\n[I_{P}]=(\\alpha-1)K_{i,P},\\quad [I_{Q}]=(\\alpha-1)K_{i,Q},\n$$\nand the ratio is\n$$\n\\frac{[I_{Q}]}{[I_{P}]}=\\frac{K_{i,Q}}{K_{i,P}}.\n$$\nSubstituting the given inhibition constants,\n$$\n\\frac{[I_{Q}]}{[I_{P}]}=\\frac{125.0}{25.0}=5.00,\n$$\nwhere the ratio is dimensionless and rounded to three significant figures as required.", "answer": "$$\\boxed{5.00}$$", "id": "1432092"}]}